Biofrontera Inc. Public Float
Biofrontera Inc. (BFRI) had Public Float of $6.90 million as of 2025-06-30, per its 10-K/A filed 2026-07-22.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-07-22
- 2025-06-30: Entity Public Float $6.90M.
- 2024-06-30: Entity Public Float $4.20M.
- 2023-06-30: Entity Public Float $14.20M.
- 2022-06-30: Entity Public Float $35.40M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $6.90M 10-K/A · filed 2026-07-22 |
| 2024-06-30 | $4.20M 10-K · filed 2025-03-20 |
| 2023-06-30 | $14.20M 10-K · filed 2024-03-15 |
| 2022-06-30 | $35.40M 10-K · filed 2023-03-13 |
| 2022-04-07 | $36.80M 10-K · filed 2022-04-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B |